Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin-loaded PRF in immediate dental implants
NCT06016218Phase 2Completed
- Sponsor
- The British University in Egypt
- Start
- Jan 2021
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of simvastatin in Alveolar bone loss, sponsored by The British University in Egypt. Primary endpoint: Changes in crestal peri-implant bone at 12 months. Started Jan 2021; status: completed.
02
Drugs
simvastatin
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT06016218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06016218.